Cargando…

Validation of a novel automated system, Fluispotter®, for serial sampling of dried blood spots

Repeated blood sampling is required in certain clinical and research settings, which is currently performed by drawing blood from venous catheters requiring manual handling of each sample at the time of collection. A novel body-worn device for repeated serial samples, Fluispotter®, with automated ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Krogh, Jesper, Plomgaard, Peter, Frikke-Schmidt, Ruth, Velschow, Sten, Johannesen, Jesper, Hilsted, Linda Maria, Schrøder, Malene, Feldt-Rasmussen, Ulla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305485/
https://www.ncbi.nlm.nih.gov/pubmed/36939600
http://dx.doi.org/10.1530/EC-23-0087
_version_ 1785065745058627584
author Krogh, Jesper
Plomgaard, Peter
Frikke-Schmidt, Ruth
Velschow, Sten
Johannesen, Jesper
Hilsted, Linda Maria
Schrøder, Malene
Feldt-Rasmussen, Ulla
author_facet Krogh, Jesper
Plomgaard, Peter
Frikke-Schmidt, Ruth
Velschow, Sten
Johannesen, Jesper
Hilsted, Linda Maria
Schrøder, Malene
Feldt-Rasmussen, Ulla
author_sort Krogh, Jesper
collection PubMed
description Repeated blood sampling is required in certain clinical and research settings, which is currently performed by drawing blood from venous catheters requiring manual handling of each sample at the time of collection. A novel body-worn device for repeated serial samples, Fluispotter®, with automated extraction, collection, and storage of up to 20 venous dried blood spot samples over the course of 20 h may overcome problems with current methods for serial sampling. The purpose of this study was to assess the performance and safety of Fluispotter for the first time in healthy subjects. Fluispotter consists of a cartridge with tubing, a reservoir for flushing solution, pumps and filterpaper, and a multi-lumen catheter placed in the brachial vein. We recruited healthy subjects for testing in an in-hospital setting. Fluispotter was attached by an anesthesiologist to 22 healthy subjects of which 9/22 (40.9%) participants had all 20 samples taken, which was lower than the goal of complete sampling in 80% of the subjects (P = 0.02). The main reason for sample failure was clogging of blood flow which was observed in 11/22 (50%) of the participants. No serious adverse events occurred, and the participants rated the pain from the insertion and the removal of catheter as very low. A cortisol profile showed nadir values at midnight and highest values at 05:00 h. Although full sampling was not successful in all participants, the Fluispotter technology proved safe and highly acceptable to the participants producing the expected cortisol profile without the requirement of staff during sample collection.
format Online
Article
Text
id pubmed-10305485
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-103054852023-06-29 Validation of a novel automated system, Fluispotter®, for serial sampling of dried blood spots Krogh, Jesper Plomgaard, Peter Frikke-Schmidt, Ruth Velschow, Sten Johannesen, Jesper Hilsted, Linda Maria Schrøder, Malene Feldt-Rasmussen, Ulla Endocr Connect Research Repeated blood sampling is required in certain clinical and research settings, which is currently performed by drawing blood from venous catheters requiring manual handling of each sample at the time of collection. A novel body-worn device for repeated serial samples, Fluispotter®, with automated extraction, collection, and storage of up to 20 venous dried blood spot samples over the course of 20 h may overcome problems with current methods for serial sampling. The purpose of this study was to assess the performance and safety of Fluispotter for the first time in healthy subjects. Fluispotter consists of a cartridge with tubing, a reservoir for flushing solution, pumps and filterpaper, and a multi-lumen catheter placed in the brachial vein. We recruited healthy subjects for testing in an in-hospital setting. Fluispotter was attached by an anesthesiologist to 22 healthy subjects of which 9/22 (40.9%) participants had all 20 samples taken, which was lower than the goal of complete sampling in 80% of the subjects (P = 0.02). The main reason for sample failure was clogging of blood flow which was observed in 11/22 (50%) of the participants. No serious adverse events occurred, and the participants rated the pain from the insertion and the removal of catheter as very low. A cortisol profile showed nadir values at midnight and highest values at 05:00 h. Although full sampling was not successful in all participants, the Fluispotter technology proved safe and highly acceptable to the participants producing the expected cortisol profile without the requirement of staff during sample collection. Bioscientifica Ltd 2023-03-20 /pmc/articles/PMC10305485/ /pubmed/36939600 http://dx.doi.org/10.1530/EC-23-0087 Text en © the author(s) https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Research
Krogh, Jesper
Plomgaard, Peter
Frikke-Schmidt, Ruth
Velschow, Sten
Johannesen, Jesper
Hilsted, Linda Maria
Schrøder, Malene
Feldt-Rasmussen, Ulla
Validation of a novel automated system, Fluispotter®, for serial sampling of dried blood spots
title Validation of a novel automated system, Fluispotter®, for serial sampling of dried blood spots
title_full Validation of a novel automated system, Fluispotter®, for serial sampling of dried blood spots
title_fullStr Validation of a novel automated system, Fluispotter®, for serial sampling of dried blood spots
title_full_unstemmed Validation of a novel automated system, Fluispotter®, for serial sampling of dried blood spots
title_short Validation of a novel automated system, Fluispotter®, for serial sampling of dried blood spots
title_sort validation of a novel automated system, fluispotter®, for serial sampling of dried blood spots
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305485/
https://www.ncbi.nlm.nih.gov/pubmed/36939600
http://dx.doi.org/10.1530/EC-23-0087
work_keys_str_mv AT kroghjesper validationofanovelautomatedsystemfluispotterforserialsamplingofdriedbloodspots
AT plomgaardpeter validationofanovelautomatedsystemfluispotterforserialsamplingofdriedbloodspots
AT frikkeschmidtruth validationofanovelautomatedsystemfluispotterforserialsamplingofdriedbloodspots
AT velschowsten validationofanovelautomatedsystemfluispotterforserialsamplingofdriedbloodspots
AT johannesenjesper validationofanovelautomatedsystemfluispotterforserialsamplingofdriedbloodspots
AT hilstedlindamaria validationofanovelautomatedsystemfluispotterforserialsamplingofdriedbloodspots
AT schrødermalene validationofanovelautomatedsystemfluispotterforserialsamplingofdriedbloodspots
AT feldtrasmussenulla validationofanovelautomatedsystemfluispotterforserialsamplingofdriedbloodspots